首页> 外文期刊>Sleep medicine >Drug Induced Sleep Endoscopy in the decision-making process of children with obstructive sleep apnea
【24h】

Drug Induced Sleep Endoscopy in the decision-making process of children with obstructive sleep apnea

机译:阻塞性睡眠呼吸暂停患儿决策过程中的药物诱导睡眠内窥镜检查

获取原文
获取原文并翻译 | 示例
       

摘要

Tonsillectomy and adenoidectomy (T&A) is currently recommended in children with Obstructive Sleep Apnea (OSA). However, the condition persists after surgery in about one third of cases. It has been suggested that Drug Induced Sleep Endoscopy (DISE) may be of help for planning a more targeted and effective surgical treatment but evidence is yet weak. The aim of this review is to draw recommendation on the use of DISE in children with OSA. More specifically, we aimed at determine the proportion of cases whose treatment may be influenced by DISE findings. A comprehensive search of articles published from February 1983 to January 2014 listed in the PubMed/MEDLINE databases was performed. The search terms used were: "endoscopy" or "nasoendoscopy" or "DISE" and "obstructive sleep apnea" and "children" or "child" or "pediatric." The main outcome was the rate of naive children with hypertrophic tonsils and/or adenoids. The assumptions are that clinical diagnosis of hypertrophic tonsils and/or adenoids is reliable and does not require DISE, and that exclusive T&A may solve OSA in the vast majority of cases even in the presence of other concomitant sites of obstruction. Five studies were ultimately selected and all were case series. The median (range) number of studied children was 39 (15-82). Mean age varied from 3.2 to 7.8 years. The combined estimate rate of OSA consequent to hypertrophic tonsils and/or adenoids was 71% (95%CI: 64-77%). In children with Down Syndrome, the combined estimated rate of hypertrophic tonsils and/or adenoids was 62% (95%CI: 44-79%). Our findings show that DISE may be of benefit in a minority of children with OSA since up to two thirds of naive cases presents with hypertrophic tonsils and/or adenoids. Its use should be limited to those whose clinical evaluation is unremarkable or when OSA persists after T&A. (C) 2014 Elsevier B.V. All rights reserved.
机译:目前,对于阻塞性睡眠呼吸暂停(OSA)儿童,建议进行扁桃体切除术和腺样体切除术(T&A)。但是,大约三分之一的病例在手术后仍然持续。已经提出,药物诱导的睡眠内窥镜检查(DISE)可能有助于计划更有针对性和更有效的手术治疗,但证据还很薄弱。这篇综述的目的是就OSA儿童中使用DISE提出建议。更具体地说,我们旨在确定其治疗可能受DISE结果影响的病例比例。对PubMed / MEDLINE数据库中列出的1983年2月至2014年1月发表的文章进行了全面搜索。使用的搜索词是:“内窥镜”或“鼻内窥镜”或“ DISE”和“阻塞性睡眠呼吸暂停”和“儿童”或“儿童”或“儿科”。主要结局是幼童患有肥厚性扁桃体和/或腺样体的比率。这些假设是,肥厚性扁桃体和/或腺样体的临床诊断是可靠的,不需要DISE,而且即使在存在其他伴随阻塞部位的情况下,独家T&A技术也可以在绝大多数情况下解决OSA。最终选择了五项研究,所有研究均为病例系列。研究儿童的中位数(范围)为39(15-82)。平均年龄从3.2岁到7.8岁不等。肥厚性扁桃体和/或腺样体增生导致的OSA合并估计率为71%(95%CI:64-77%)。在患有唐氏综合症的儿童中,肥厚性扁桃体和/或腺样体的综合估计率为62%(95%CI:44-79%)。我们的研究结果表明,DISE可能对少数OSA儿童有益,因为多达三分之二的未婚病例都存在肥大的扁桃体和/或腺样体。它的使用应限于那些临床评价不明显或OSA在T&A后仍持续的患者。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号